1. Home
  2. CYTK
  3. CYTK News

Latest Cytokinetics Incorporated (CYTK) News on February 22, 2025

Cytokinetics, Incorporated (CYTK): One of the Most Oversold Healthcare Stocks to Buy Now
CYTK

Insider Monkey

2 days ago

Cytokinetics, Incorporated (CYTK): One of the Most Oversold Healthcare Stocks to Buy Now

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CYTK

Zacks

2 days ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

3 days ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

Argus Research

4 days ago

CYTK: Raising target price to $36.00

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
CYTK

GlobeNewswire

9 days ago

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

CYTK

MT Newswires

9 days ago

Morgan Stanley Upgrades Cytokinetics to Overweight From Equalweight, Adjusts Price Target to $67 From $70

CYTK

MT Newswires

9 days ago

Morgan Stanley Upgrades Cytokinetics to Overweight From Equalweight, Trims Price Target to $67 From $70

Cytokinetics Names Robert E. Landry to Board of Directors
CYTK

GlobeNewswire

11 days ago

Cytokinetics Names Robert E. Landry to Board of Directors

Why Cytokinetics, Incorporated (CYTK) Is Among the Best Healthcare Stocks To Buy According to Analysts
CYTK

Insider Monkey

14 days ago

Why Cytokinetics, Incorporated (CYTK) Is Among the Best Healthcare Stocks To Buy According to Analysts

CYTK

MT Newswires

15 days ago

Citigroup Initiates Cytokinetics at Buy With $86 Price Target

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CYTK

GlobeNewswire

17 days ago

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CYTK

MT Newswires

17 days ago

B. Riley Adjusts Cytokinetics' Price Target to $88 From $92, Keeps Buy Rating

CYTK

Argus Research

18 days ago

CYTK: What does Argus have to say about CYTK?

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

18 days ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics
CYTK

Zacks

23 days ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program
CYTK

GlobeNewswire

23 days ago

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates
CYTK

Zacks

24 days ago

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates

CYTK

Argus Research

25 days ago

CYTK: Raising target price to $39.00

What Are Analysts Talking About Cytokinetics (CYTK)?
CYTK

Insider Monkey

a month ago

What Are Analysts Talking About Cytokinetics (CYTK)?

CYTK Stock Rises as Enrollment Begins in Phase II Heart Failure Study
CYTK

Zacks

a month ago

CYTK Stock Rises as Enrollment Begins in Phase II Heart Failure Study

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
CYTK

Benzinga

a month ago

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst

CYTK

Argus Research

a month ago

CYTK: Raising target price to $37.00

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction
CYTK

GlobeNewswire

a month ago

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction

CYTK

Argus Research

a month ago

CYTK: Lowering target price to $36.00

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
CYTK

GlobeNewswire

a month ago

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CYTK

GlobeNewswire

2 months ago

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CYTK

Argus Research

2 months ago

CYTK: Raising target price to $51.00

CYTK

MT Newswires

2 months ago

Cytokinetics Says European Regulator Validated its Application for Cardiomyopathy Drug Candidate

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Why Cytokinetics Stock Was a Nearly 5% Winner Today
CYTK

Motley Fool

2 months ago

Why Cytokinetics Stock Was a Nearly 5% Winner Today

CYTK

MT Newswires

2 months ago

Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
CYTK

Simply Wall St.

2 months ago

Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)

CYTK

MT Newswires

2 months ago

RBC Raises Price Target on Cytokinetics to $82 From $80, Keeps Outperform, Speculative Risk

CYTK

Argus Research

2 months ago

CYTK: Lowering target price to $50.00

CYTK

Argus Research

2 months ago

CYTK: Rating increased to a HOLD

CYTK

MT Newswires

2 months ago

Cytokinetics Insider Sold Shares Worth $369,639, According to a Recent SEC Filing

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
CYTK

Zacks

3 months ago

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Cytokinetics Initiates Confirmatory Study on Heart Failure Drug
CYTK

Zacks

3 months ago

Cytokinetics Initiates Confirmatory Study on Heart Failure Drug

CYTK

Argus Research

3 months ago

CYTK: Lowering target price to $41.00

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

FDA Accepts Cytokinetics' Application for Cardiovascular Drug
CYTK

Zacks

3 months ago

FDA Accepts Cytokinetics' Application for Cardiovascular Drug

CYTK

MT Newswires

3 months ago

Cytokinetics Begins Phase 3 Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

Cytokinetics to Participate in December Investor Conferences
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Participate in December Investor Conferences

CYTK

MT Newswires

3 months ago

Cytokinetics Says US FDA Accepts New Drug Application for Aficamten to Treat Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
CYTK

BioPharma Dive

3 months ago

Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date

Cytokinetics price target raised to $103 from $99 at Mizuho
CYTK

TipRanks

3 months ago

Cytokinetics price target raised to $103 from $99 at Mizuho

Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
CYTK

Insider Monkey

3 months ago

Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
CYTK

Zacks

3 months ago

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
CYTK

BioPharma Dive

3 months ago

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer

CYTK

MT Newswires

3 months ago

Cytokinetics, Bayer Partner to Develop, Commercialize Potential Cardiomyopathy Treatment in Japan

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
CYTK

GuruFocus.com

3 months ago

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan

Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
CYTK

GuruFocus.com

3 months ago

Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan

Bayer acquires rights to Cytokinetics' heart drug in Japan
CYTK

Reuters

3 months ago

Bayer acquires rights to Cytokinetics' heart drug in Japan

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
CYTK

GlobeNewswire

3 months ago

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

3 months ago

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

3 months ago

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

CYTK

MT Newswires

3 months ago

Cytokinetics Insider Sold Shares Worth $370,880, According to a Recent SEC Filing

CYTK

Argus Research

3 months ago

CYTK: Raising target price to $45.00

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference

CYTK

MT Newswires

3 months ago

Cytokinetics Doses First Participants in Study of Potential Muscular Dystrophy Treatment

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089

CYTK

MT Newswires

3 months ago

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations
CYTK

Simply Wall St.

3 months ago

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations

CYTK

MT Newswires

3 months ago

Cytokinetics Q3 Loss Widens, Revenue Rises

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
CYTK

GuruFocus.com

3 months ago

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
CYTK

Zacks

4 months ago

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates

CYTK

Associated Press Finance

4 months ago

Cytokinetics: Q3 Earnings Snapshot

Cytokinetics Reports Third Quarter 2024 Financial Results
CYTK

GlobeNewswire

4 months ago

Cytokinetics Reports Third Quarter 2024 Financial Results

CYTK

Argus Research

4 months ago

CYTK: Raising target price to $42.00

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result
CYTK

GuruFocus.com

4 months ago

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics to Announce Third Quarter Results on November 6, 2024
CYTK

GlobeNewswire

4 months ago

Cytokinetics to Announce Third Quarter Results on November 6, 2024

Is Cytokinetics Inc. (CYTK) the Most Promising Biotech Stock According to Hedge Funds?
CYTK

Insider Monkey

4 months ago

Is Cytokinetics Inc. (CYTK) the Most Promising Biotech Stock According to Hedge Funds?

Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day
CYTK

GlobeNewswire

4 months ago

Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day

CYTK

MT Newswires

4 months ago

Cytokinetics Insider Sold Shares Worth $278,050, According to a Recent SEC Filing

Cytokinetics Inc (CYTK) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
CYTK

GuruFocus.com

4 months ago

Cytokinetics Inc (CYTK) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

CYTK

Argus Research

4 months ago

CYTK: Rating decreased to a SELL

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics to Host Investor & Analyst Day on October 16, 2024
CYTK

GlobeNewswire

5 months ago

Cytokinetics to Host Investor & Analyst Day on October 16, 2024

Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
CYTK

Insider Monkey

5 months ago

Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?

Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
CYTK

GlobeNewswire

5 months ago

Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting

CYTK

MT Newswires

5 months ago

Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes

Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
CYTK

GlobeNewswire

5 months ago

Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions

Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program

How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart Disease
CYTK

Investor's Business Daily

5 months ago

How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart Disease

Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

CYTK

MT Newswires

5 months ago

Cytokinetics Insider Sold Shares Worth $414,401, According to a Recent SEC Filing

Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study
CYTK

Benzinga

5 months ago

Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study

CYTK

MT Newswires

5 months ago

Cytokinetics Reports Phase 1 Study of CK-4021586 Meets Targets, Plans Mid-Stage Trial in Q4

Cytokinetics Announces Data From Phase 1 Study of CK-4021586
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Data From Phase 1 Study of CK-4021586

Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?
CYTK

Insider Monkey

5 months ago

Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?

Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting
CYTK

GlobeNewswire

6 months ago

Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

6 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

6 months ago

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

Share on Social Networks: